REXO4 Antibody

Code CSB-PA019587GA01HU
Size $600
Order now
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Uniprot No.
Target Names
REXO4
Alternative Names
REXO4; PMC2; XPMC2H; RNA exonuclease 4; Exonuclease XPMC2; Prevents mitotic catastrophe 2 protein homolog; hPMC2
Raised in
Rabbit
Species Reactivity
Human,Mouse,Rat
Immunogen
Human REXO4,REX4
Immunogen Species
Homo sapiens (Human)
Isotype
IgG
Purification Method
Antigen Affinity purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. -20°C, Avoid freeze / thaw cycles.
Tested Applications
ELISA,WB,IHC
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Gene References into Functions
  1. determined that the catalytic activity of hPMC2 is required for repair of abasic sites that result from estrogen-induced DNA damage PMID: 21602889
Subcellular Location
Nucleus, nucleolus.
Protein Families
REXO4 family
Database Links

HGNC: 12820

OMIM: 602930

KEGG: hsa:57109

STRING: 9606.ENSP00000361010

UniGene: Hs.438409

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*